Growth Metrics

Johnson & Johnson (JNJ) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Johnson & Johnson (JNJ) over the last 17 years, with Q3 2025 value amounting to $2.4 billion.

  • Johnson & Johnson's Shares Outstanding (Weighted Average) rose 3.74% to $2.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 billion, marking a year-over-year increase of 3.74%. This contributed to the annual value of $2.4 billion for FY2024, which is 498.13% down from last year.
  • Per Johnson & Johnson's latest filing, its Shares Outstanding (Weighted Average) stood at $2.4 billion for Q3 2025, which was up 3.74% from $2.4 billion recorded in Q2 2025.
  • Over the past 5 years, Johnson & Johnson's Shares Outstanding (Weighted Average) peaked at $2.6 billion during Q1 2021, and registered a low of $2.4 billion during Q2 2025.
  • Its 5-year average for Shares Outstanding (Weighted Average) is $2.5 billion, with a median of $2.6 billion in 2023.
  • In the last 5 years, Johnson & Johnson's Shares Outstanding (Weighted Average) plummeted by 757.24% in 2024 and then increased by 3.74% in 2025.
  • Quarter analysis of 5 years shows Johnson & Johnson's Shares Outstanding (Weighted Average) stood at $2.6 billion in 2021, then fell by 0.14% to $2.6 billion in 2022, then dropped by 3.63% to $2.5 billion in 2023, then fell by 4.98% to $2.4 billion in 2024, then rose by 0.04% to $2.4 billion in 2025.
  • Its last three reported values are $2.4 billion in Q3 2025, $2.4 billion for Q2 2025, and $2.4 billion during Q1 2025.